Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms

Abstract Interest in the therapeutic potential of serotonergic psychedelic compounds including psilocybin has surged in recent years. While human clinical research suggests psilocybin holds promise as a rapid and long-lasting antidepressant, little is known about how its acute mechanisms of action m...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Meccia, Juliet [verfasserIn]

Lopez, Joëlle

Bagot, Rosemary C.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Schlagwörter:

Psilocybin

Psychedelics

Depression

Medial prefrontal cortex

Preclinical models

Affect

Cognition

Anmerkung:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Übergeordnetes Werk:

Enthalten in: Psychopharmacology - Berlin : Springer, 1959, 240(2022), 1 vom: 24. Dez., Seite 27-40

Übergeordnetes Werk:

volume:240 ; year:2022 ; number:1 ; day:24 ; month:12 ; pages:27-40

Links:

Volltext

DOI / URN:

10.1007/s00213-022-06297-0

Katalog-ID:

SPR048989819

Nicht das Richtige dabei?

Schreiben Sie uns!